To this aim, we exposed LOX IMVI sensitive melanoma cells to increasing concentrations of a BRAFi for two months and at each step of drug increase we collected total RNAs from samples to evaluate the levels of mir-579-3p, MITF, TYR, and AXL by qRT-PCR. Here, MITF is linked to melanoma.